首页> 外国专利> Convention on civil liability for damage caused by acts not prohibited by international law

Convention on civil liability for damage caused by acts not prohibited by international law

机译:因国际法未加禁止的行为造成损害的民事责任公约

摘要

1. Characteristic 1: a single protein that binds to ilt7. Its characteristic is that it can be combined with the same top end of the International Plant Protection Convention 7. The antibody includes a variable heavy chain region of CAS No. 202 and a variable light chain region of CAS No. 207. Claim 29: a separated polynuclear acid, characterized in that it contains a nucleic acid capable of encoding VH, wherein VH includes at least 85% amino acid sequence,90%95% is identical, or the same as Memorandum No. 202, 12, 22, 32, 42, 52, 62, 72, 82, 92, 102, 112, 122, 132, 142, 152, 162, 172, 182, 192, 212, 222, 232 or 242. Requirement 38: host cell, characterized by the transformation of polynucleotide required in item 29 or 30 and polynucleotide required in item 31 or 32. Claim 43: a method of producing an anti ilt7 binding molecule characterized by culturing any of the 38-42 required host cells and recovering the binding molecule.It is characterized by (a) attachment to ilt7 molecules in 1-27 or 44 claims, polynucleotides in 29-35 claims, vectors in 36 claims, peptides in 37 claims or host cells in 28 or 38-42 claims, and (b) vehicles. Claim 50: a method for preventing autoimmune diseases of human body, characterized by the effective management of the binding molecule of any one of claims 1-27 or 44, the polynucleoside of any one of claims 29-35, and the carrier of 36 claims to patients.The polypeptide of claim 37, the host cell of claim 28 or 38-42, or the composition of claim 47.
机译:1.特征1:与il​​t7结合的单一蛋白质。它的特征是可以与《国际植物保护公约》 7的同一顶端组合。该抗体包括CAS号202的可变重链区和CAS号207的轻链区。权利要求29:a分离的多核酸,其特征在于,其包含能够编码VH的核酸,其中VH包含至少85%的氨基酸序列,90%95%与第202、12、22、32号备忘录相同或相同, 42、52、62、72、82、92、102、112、122、132、142、152、162、172、182、192、212、222、232或242。要求38:宿主细胞,其特征在于转化29.权利要求43:产生抗ilt7结合分子的方法,其特征在于,培养38-42个所需宿主细胞中的任何一种并回收结合分子。 (a)附着于1-27或44项权利要求中的ilt7分子,29-35项中的多核苷酸,载体36.权利要求36的肽,37权利要求的肽或28或38-42权利要求的宿主细胞,和(b)运载体。权利要求50:一种预防人体自身免疫疾病的方法,其特征在于有效管理权利要求1-27或44中任一项所述的结合分子,权利要求29-35中任一项所述的多核苷以及权利要求36所述的载体。 38.权利要求37的多肽,权利要求28或38-42的宿主细胞或权利要求47的组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号